AI Summary
We reviewed 36 live results for amgevita (adalimumab atto) and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Biosimilar and Pharmaceuticals.
Comparison Table
Recommended
Amgevita (adalimumab-atto)
Source: Amgen (Thailand) Limited
Description
Amgevita is a biosimilar to Humira, containing the active substance adalimumab. It is used as a biologic therapy for inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, and plaque psoriasis. Available in Thailand as a solution for injection in 20 mg/0.4 ml and 40 mg/0.8 ml pre-filled syringes or autoinjectors, it is classified as a Special Controlled Drug that requires professional medical supervision for prescription and dispensing.
Best for
rheumatoid arthritis patients, biosimilar drug preference, chronic inflammation management and specialized biologic therapy
View Details
Rating
Amjevita (adalimumab-atto)
Source: Amgen Inc.
Description
Amjevita is a prescription biosimilar to Humira (adalimumab) available in the United States. It is used to treat several inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and plaque psoriasis. This citrate-free medication is delivered via the SureClick autoinjector or single-dose prefilled syringes in various dosages such as 40 mg and 20 mg.
Best for
rheumatoid arthritis patients, US healthcare users, Humira biosimilar seekers and chronic inflammation management
View Details
Rating
Amgevita
Source: Amgen Biotechnology Singapore Pte Ltd
Description
Amgevita is a biosimilar to Humira (adalimumab) registered in Singapore for the treatment of various inflammatory conditions, including rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis. As an anti-inflammatory biologic, it provides a high-quality, cost-effective alternative for patients managing chronic autoimmune diseases.
Best for
rheumatoid arthritis patients, plaque psoriasis treatment and cost-effective biologic access
View Details
Rating
| Compare | Amgevita (adalimumab-atto) | Amjevita (adalimumab-atto) | Amgevita |
|---|---|---|---|
| Source | Amgen (Thailand) Limited | Amgen Inc. | Amgen Biotechnology Singapore Pte Ltd |
| Description | Amgevita is a biosimilar to Humira, containing the active substance adalimumab. It is used as a biologic therapy for inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, and plaque psoriasis. Available in Thailand as a solution for injection in 20 mg/0.4 ml and 40 mg/0.8 ml pre-filled syringes or autoinjectors, it is classified as a Special Controlled Drug that requires professional medical supervision for prescription and dispensing. | Amjevita is a prescription biosimilar to Humira (adalimumab) available in the United States. It is used to treat several inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and plaque psoriasis. This citrate-free medication is delivered via the SureClick autoinjector or single-dose prefilled syringes in various dosages such as 40 mg and 20 mg. | Amgevita is a biosimilar to Humira (adalimumab) registered in Singapore for the treatment of various inflammatory conditions, including rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis. As an anti-inflammatory biologic, it provides a high-quality, cost-effective alternative for patients managing chronic autoimmune diseases. |
| Best for | rheumatoid arthritis patients, biosimilar drug preference, chronic inflammation management and specialized biologic therapy | rheumatoid arthritis patients, US healthcare users, Humira biosimilar seekers and chronic inflammation management | rheumatoid arthritis patients, plaque psoriasis treatment and cost-effective biologic access |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
AI Recommendation
If you want the most balanced option to start with, I recommend:
"Amgevita (adalimumab-atto) from Amgen (Thailand) Limited."
I picked this because Amgevita is a reputable biosimilar offering from Amgen, providing a more accessible treatment option for patients requiring adalimumab with proven safety and efficacy profiles.
Share this search
Related Finds